CurrentCardio coverage · page 16 of 17
JACC
Latest from JACC
J Am Coll Cardiol
Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events
Meta-analysisPrevention & lipids
J Am Coll Cardiol
Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction
Cohort studyAcute care & resuscitation
J Am Coll Cardiol
J Am Coll Cardiol
Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial Infarction
Cohort studyCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device
Secondary analysisHeart failure
J Am Coll Cardiol
J Am Coll Cardiol
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison
Research articleValvular & structural
J Am Coll Cardiol
Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death
Cohort studyArrhythmias & EP
J Am Coll Cardiol
Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion
Meta-analysisArrhythmias & EP
J Am Coll Cardiol
Fatal Cardiac Arrhythmias During Electronic Gaming in Patients With Genetically Mediated Heart Diseases
Cohort studyArrhythmias & EP
J Am Coll Cardiol
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week
Research articleCoronary & ACS
J Am Coll Cardiol
Pulmonary Artery Hypoplasia in Neonates With Tetralogy of Fallot
Cohort studyCongenital
J Am Coll Cardiol
J Am Coll Cardiol
High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease
Cohort studyCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease
Cohort studyHeart failure
J Am Coll Cardiol
Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention
Cohort studyCoronary & ACS
J Am Coll Cardiol
Global Comparison of Readmission Rates for Patients With Heart Failure
Meta-analysisHeart failure
J Am Coll Cardiol
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System
Cohort studyArrhythmias & EP
J Am Coll Cardiol
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial
Secondary analysisCoronary & ACS
J Am Coll Cardiol
J Am Coll Cardiol
Dispatch of Volunteer Responders to Out-of-Hospital Cardiac Arrests
Cohort studyAcute care & resuscitation
J Am Coll Cardiol
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure
Secondary analysisHeart failure
J Am Coll Cardiol
Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients
Randomised controlled trialValvular & structural
J Am Coll Cardiol
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
Meta-analysisCoronary & ACS
J Am Coll Cardiol
Cognitive Behavioral Therapy Improves Quality of Life in Patients With Symptomatic Paroxysmal Atrial Fibrillation
Randomised controlled trialArrhythmias & EP
J Am Coll Cardiol
Long-Term Outcomes of Women With Peripartum Cardiomyopathy Having Subsequent Pregnancies
Cohort studyCardio-oncology & other
J Am Coll Cardiol
Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results
Randomised controlled trialCardio-oncology & other
J Am Coll Cardiol
Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus
Diagnostic or prognostic study
J Am Coll Cardiol
J Am Coll Cardiol
Mortality in Patients With Ebstein Anomaly
Cohort study
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
J Am Coll Cardiol
Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial
Secondary analysisValvular & structural
J Am Coll Cardiol